Molecule

methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate

Chemical Information

30 Related Dataset(s) ⌄

methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate; LC-APCI-QTOF; MS; POSITIVE

methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate; LC-ESI-QTOF; MS2; CE 10 ev; [M]+

methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate; LC-ESI-QTOF; MS2; CE 20 ev; [M]+

methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate; LC-ESI-QTOF; MS2; CE 40 ev; [M]+

methyl (2S,13bS,14aS,1R,4aR)-2-hydroxy-1,2,3,4,5,8,14,13b,14a,4a-decahydrobenz o[1,2-g]indolo[2,3-a]quinolizinecarboxylate; LC-ESI-QTOF; MS; POSITIVE

Yohimbine; LC-ESI-ITFT; MS2; CE: 10%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 100%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 105%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 20%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 25%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 35%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 55%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 65%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 75%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 85%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+

Yohimbine; LC-ESI-ITFT; MS2; CE: 95%; R=15000; [M+H]+

Yohimbine; LC-ESI-Q; MS; POS; 15 V

Yohimbine; LC-ESI-Q; MS; POS; 30 V

Yohimbine; LC-ESI-Q; MS; POS; 45 V

Yohimbine; LC-ESI-Q; MS; POS; 60 V

Yohimbine; LC-ESI-Q; MS; POS; 75 V, 90 V

Metadata Information

Field	Value
NFDI4Chem Molecule ID	nfdi4chem-mol55038
Source
Alternate Name

Field	Value
No additional information available for this Dataset.

Data-Source Molecule ID	Data-Source
SCHEMBL33954	SureChEMBL
MCULE-1043513122	Mcule
CB4129677	ChemicalBook
yohimbine	DailyMed
HMDB0015464	Human Metabolome Database
95376	Brenda
ZINC000003860825	ZINC
MTBLC10093	Metabolights
60026147	NMRShiftDB
PD009520	ProbesDrugs
yohimbine	Atlas
2Y49VWD90Q	FDA SRS
14754428	PubChem: Thomson Pharma
146-48-5	ACToR
PA451946	PharmGKB
14852160	PubChem: Thomson Pharma
LSM-2779	LINCS
1933610	eMolecules
C09256	KEGG Ligand
CHEMBL15245	ChEMBL
10093	ChEBI
DB01392	DrugBank
8969	PubChem
YOHIMBINE	clinicaltrials
YOHIMBINE HYDROCHLORIDE	clinicaltrials
HY-12715	MedChemExpress
YOCON	rxnorm
YOHIMBINE	rxnorm
YOHIMBINE HYDROCHLORIDE	rxnorm
YOHIMBINE	DailyMed
50203564	BindingDB
50013515	BindingDB
ZZZSHG	CCDC
J9.366A	Nikkaji
102	Guide to Pharmacology
3659	DrugCentral
DTXSID9040130	EPA CompTox Dashboard
The data in this table is sourced from UniChem at EBI.